 |
|
|
| |
Safety, Pharmacokinetics, and Pharmacodynamics of Oral TLR8 Agonist GS-9688 in Patients With Chronic Hepatitis B: a Randomized, Placebo-Controlled, Double-blind Phase 1b Study
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Ed Gane,1 Hyung Joon Kim,2 Kumar Visvanathan,3 Yoon Jun Kim,4 Anh-Hoa Nguyen,5 Adarsh Joshi,5 Maribel Reyes,5 Audrey H. Lau,5 Anuj Gaggar,5 G. Mani Subramanian,5 Stuart K. Roberts,6 Young-Suk Lim7
1Auckland City Hospital, Auckland, New Zealand; 2Chung-Ang University Hospital, Seoul, South Korea; 3St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; 4Seoul National University Hospital, Seoul; 5Gilead Sciences, Inc., Foster City, CA; 6The Alfred, Melbourne; 7Asan Medical Center, Seoul
|
| |
|
|
|
|
|
